Atherosclerosis
Volume 185, Issue 2 , Pages 240-245 , April 2006

Statins prevent NF-κB transactivation independently of the IKK-pathway in human endothelial cells

Received 29 July 2004 ,Revised 15 June 2005 ,Accepted 20 June 2005.

References 

  1. Karin M, Delhase M. The IκB-kinase (IKK) and NF-κB: key elements of proinflammatory signaling. Semin Immunol. 2000;12:85–98
  2. Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S. Rel/NF-κB family: intimate tales of association and dissociation. Genes Develop. 1995;15:2723–2735
  3. Mercurio F, Manning AM. Multiple signals converging on NF-κB. Curr Opin Cell Biol. 1999;11:226–232
  4. Jaffe EA, Nachman RL, Becker CG, et al. Culture of human endothelial cells derived from umbilical veins identification by morphologic and immunologic criteria. J Clin Invest. 1973;52:2745–2751
  5. Hölschermann H, Dürfeld F, Haberbosch W, et al. Cyclosporin A inhibits tissue factor expression in monocytes/macrophages. Blood. 1996;88:3837–3845
  6. Chomczynski P, Sacchi N. Singel step method of RNA-isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156–159
  7. Hilgendorff A, Muth H, Hölschermann H, et al. Statins differ in their ability to block NF-κB activation in human blood monocytes. Clin Pharm Therap. 2003;41:397–401
  8. Patel TR, Corbett SA. Simvastatin supresses LPS-induced Akt phosphorylation in the human monocyte cell line THP-1. J Surg Res. 2004;116:116–120
  9. Fukuyama R, Fujita T, Azuma Y, et al. Statins inhibit osteoblast migration by inhibiting Rac–Akt signaling. Biochem Biophys Res Commun. 2004;315:636–642
  10. Hippenstiel S, Schmeck B, Suttorp N, et al. Reduction of tumor necrosis factor-α (TNF-α) related nuclear factor-κB (NF-κB) translocation but not inhibitorκ-B (Iκ-B)-degradation by Rho protein inhibition in human endothelial cells. Biochem Pharmacol. 2002;64:971–979
  11. Dimmeler S, Aicher A, Vasa M, et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI3-kinase/Akt pathway. J Clin Invest. 2001;108:391–397

PII: S0021-9150(05)00394-1

doi: 10.1016/j.atherosclerosis.2005.06.019

Atherosclerosis
Volume 185, Issue 2 , Pages 240-245 , April 2006